The mixture of “ecstasy” and its metabolites is toxic to human SH-SY5Y differentiated cells at in vivo relevant concentrations
- 8 October 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archives of Toxicology
- Vol. 88 (2), 455-473
- https://doi.org/10.1007/s00204-013-1120-7
Abstract
The neurotoxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA) is thought to involve hepatic metabolism, though its real contribution is not completely understood. Most in vitro neurotoxicity studies concern isolated exposures of MDMA or its metabolites, at high concentrations, not considering their mixture, as expected in vivo. Therefore, our postulate is that combined deleterious effects of MDMA and its metabolites, at low micromolar concentrations that may be attained into the brain, may elicit neurotoxicity. Using human SH-SY5Y differentiated cells as dopaminergic neuronal model, we studied the neurotoxicity of MDMA and its MDMA metabolites α-methyldopamine and N-methyl-α-methyldopamine and their correspondent glutathione and N-acetylcysteine monoconjugates, under isolated exposure and as a mixture, at normothermic or hyperthermic conditions. The results showed that the mixture of MDMA and its metabolites was toxic to SH-SY5Y differentiated cells, an effect potentiated by hyperthermia and prevented by N-acetylcysteine. As a mixture, MDMA and its metabolites presented a different toxicity profile, compared to each compound alone, even at equimolar concentrations. Caspase 3 activation, increased reactive oxygen species production, and intracellular Ca2+ raises were implicated in the toxic effect. The mixture increased intracellular glutathione levels by increasing its de novo synthesis. In conclusion, this study demonstrated, for the first time, that the mixture of MDMA and its metabolites, at low micromolar concentrations, which represents a more realistic approach of the in vivo scenario, elicited toxicity to human SH-SY5Y differentiated cells, thus constituting a new insight into the context of MDMA-related neurotoxicity.Keywords
This publication has 57 references indexed in Scilit:
- The permeability transition pore as a Ca2+ release channel: New answers to an old questionCell Calcium, 2012
- Cytochrome P450 enzymes in the brain: emerging evidence of biological significanceTrends in Pharmacological Sciences, 2011
- Pro‐oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomesBritish Journal of Pharmacology, 2011
- NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy LevelsPLOS ONE, 2011
- How Addictive Drugs Disrupt Presynaptic Dopamine NeurotransmissionNeuron, 2011
- Evidence of Neurotoxicity of Ecstasy: Sustained Effects on Electroencephalographic Activity in Polydrug UsersPLOS ONE, 2010
- Chronic Stress Enhances the Corticosterone Response and Neurotoxicity to +3,4-Methylenedioxymethamphetamine (MDMA): The Role of Ambient TemperatureThe Journal of pharmacology and experimental therapeutics, 2010
- THC Prevents MDMA Neurotoxicity in MicePLOS ONE, 2010
- Further Studies on the Role of Metabolites in (±)-3,4-Methylenedioxymethamphetamine-Induced Serotonergic NeurotoxicityDrug Metabolism and Disposition, 2009
- Direct Comparison of (±) 3,4-Methylenedioxymethamphetamine (“Ecstasy”) Disposition and Metabolism in Squirrel Monkeys and HumansTherapeutic Drug Monitoring, 2009